5 Best Performing Biotech ETFs in 2024
The Putnam BioRevolution ETF (NYSE:SYNB) is designed to pursue long-term capital growth by investing in a carefully curated portfolio of 30-50 stocks.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | 1,456,300 | $186,260,770 | -13% | 0.42% | |
2. | Bronte Capital John Hempton | 262,399 | $39,261,464 | -1% | 3.19% |
3. | 25,300 | $3,235,870 | -26% | 0.01% | |
4. | Bailard Inc Thomas Bailard | 5,561 | $711,252 | +1% | 0.02% |
5. | Humankind Investments James Katz | 4,500 | $575,550 | 0.15% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 3,208,144 | $410,321,591 | 0.21% | |
2. | 1,415,130 | $180,995,127 | 0.03% | |
3. | 884,128 | $113,080,002 | 0.03% | |
4. | 599,700 | $76,701,628 | 0.49% | |
5. | 529,604 | $67,736,361 | 0.01% |